Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, EVEREST GROUP, LTD. insiders sold a net $272.7K of stock across 16 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 9.5% of the 8,170 shares held after it.
No other insider sold within 30 days.
346 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & CEO of GW & S Division Keen Jason sold about $272.7K of EG on May 7, 2026, the largest insider sale at the company since 2025; 346 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 74.6% of the 4,153 shares held after it.
1 other insider bought within 30 days.
346 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Levine Allan bought about $948.8K of EG on Oct 29, 2025; 1 other insider bought within 30 days and 346 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Nov 4, 2024.
The trade is 25.0% of the 45,491 shares held after it.
1 other insider bought within 30 days.
346 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director GALTNEY WILLIAM F JR bought about $3.5M of EG on Oct 29, 2025, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 346 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 9, 2024.
The trade is 12.2% of the 12,279 shares held after it.
1 other insider sold within 30 days.
346 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Losquadro Geraldine sold about $540.9K of EG on Mar 18, 2025, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 346 funds added in the latest 13F quarter.
16 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
EG planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
EG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Vulcan Value Partners Small Cap Fund
$5.2M position · as of 2026-07-31
6.4%
Vulcan Value Partners Fund
$10.1M position · as of 2026-07-31
4.4%
ICON CONSUMER SELECT
$1.1M position · as of 2026-06-30
4.4%
FULLERTHALER BEHAVIORAL MID-CAP VALUE
$13.9M position · as of 2026-06-30
4.1%
Invesco KBW Property & Casualty Insurance ETF
$9.8M position · as of 2026-05-31
4.1%
NORTH SQUARE ALTRINSIC INTERNATIONAL EQUITY FUND
$2.2M position · as of 2026-05-31
2.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Jim Williamson
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.0M
$8.6M
$3.8M
+62%
+134%
2024
$7.9M
$9.1M
$3.7M
+69%
+113%
2023
$9.9M
$11.0M
$3.1M
+61%
+57%
2022
$9.1M
$12.0M
$3.3M
+48%
+42%
2021
$8.9M
$10.9M
$3.2M
+20%
+19%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $272.7K sold by insiders over 180 days, 346 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$16.8B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM EG
FY Dec 2025
$17.5B
FY Dec 2024
$17.3B
FY Dec 2023
$14.6B
FY Dec 2022
$12.1B
FY Dec 2021
$11.9B
Jun 2026
$4.0B
Mar 2026
$4.1B
Dec 2025
$4.4B
Sep 2025
$4.3B
Jun 2025
$4.5B
Mar 2025
$4.3B
Dec 2024
$4.6B
Sep 2024
$4.3B
At each fiscal year end
Single quarter
Net margin, TTM
+11.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM EG
FY Dec 2025
+9.1%
FY Dec 2024
+7.9%
FY Dec 2023
+17.3%
FY Dec 2022
+5.0%
FY Dec 2021
+11.6%
Jun 2026
+14.1%
Mar 2026
+16.1%
Dec 2025
+10.1%
Sep 2025
+5.9%
Jun 2025
+15.1%
Mar 2025
+4.9%
Dec 2024
-12.8%
Sep 2024
+11.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity EG
FY Dec 2025
+10.8%
FY Dec 2024
+10.1%
FY Dec 2023
+23.3%
FY Dec 2022
+6.4%
FY Dec 2021
+13.9%
Jun 2026
+12.6%
Mar 2026
+13.8%
Dec 2025
+10.8%
Sep 2025
+3.6%
Jun 2025
+5.5%
Mar 2025
+6.1%
Dec 2024
+10.1%
Sep 2024
+20.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets EG
FY Dec 2025
+2.7%
FY Dec 2024
+2.6%
FY Dec 2023
+5.6%
FY Dec 2022
+1.5%
FY Dec 2021
+3.9%
Jun 2026
+3.1%
Mar 2026
+3.4%
Dec 2025
+2.7%
Sep 2025
+0.9%
Jun 2025
+1.4%
Mar 2025
+1.6%
Dec 2024
+2.6%
Sep 2024
+5.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.43x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing EG
FY Dec 2025
8.97x
FY Dec 2024
11.42x
FY Dec 2023
5.90x
FY Dec 2022
21.98x
FY Dec 2021
7.94x
Jun 2026
7.56x
Mar 2026
6.65x
Dec 2025
8.97x
Sep 2025
26.00x
Jun 2025
17.72x
Mar 2025
18.37x
Dec 2024
11.42x
Sep 2024
6.12x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield EG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.06x
P/E over trailing EPS growth of 146%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing EG
FY Dec 2025
0.47x
FY Dec 2024
n/a
FY Dec 2023
0.02x
FY Dec 2022
n/a
FY Dec 2021
0.05x
Jun 2026
0.05x
Mar 2026
0.04x
Dec 2025
0.47x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.32x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
EG ranks highest on institutional and government (58th percentile) and profitability (48th), and lowest on risk and compliance (21st), among Insurance peers.
Profitability
48
Inputs
Return on equity+12.6% · 44 pct, sector of 116
Return on assets+3.1% · 51 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
24
Inputs
Revenue growth, YoY+1.2% · 24 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
36
Inputs
Net Form 4 buying (codes P and S), 180d-$273K · 73 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
58
Inputs
Funds adding, latest quarter346 · 77 pct, sector of 108
Congress net buyers, 365d0 · 40 pct, universe of 719
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
21
Inputs
Short interest, % of float+4.6% · 37 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+24.4% · 5 pct, sector of 110
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EG filings, in plain words
Are Everest insiders buying or selling EG?
In the 180 days to 2026-10-27, Everest insiders were net sellers, a net $272.7K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded EG?
Yes. In the year to 2026-10-27, 1 House member disclosed buying EG and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-03-13.
Read the full summary
In the 180 days to 2026-10-27, Everest insiders were net sellers of EG, a net $272.7K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-27, 1 member of Congress disclosed buying EG and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-03-13. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.